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Abstract 
Patients with multiple sclerosis (MS) have long been known to suffer deterioration of the retina, 
sometimes leading to blindness. The damage has been assumed to occur predominantly within 
the retinal nerve fiber layer. Using optical coherence tomography (OCT), researchers at Johns 
Hopkins University have determined that there is a subset of MS patients for whom the retinal 
deterioration is different. For this group the deterioration occurs at a deeper level within the 
retina, between the photoreceptors and the connecting cells. This deterioration affects the 
inner and outer nuclear layers of the retina. These findings are perplexing, as MS is considered 
primarily a demyelinating disease, and the retinal cell structures are unmyelinated.  
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Introduction 
In the spring of 2013, each of my family members contracted a mild stomach virus. Each 
of us recovered in a couple of days, but then my mother relapsed. She became sicker as the 
days passed, and then, strangely, the right side of her body began to go numb. When the right 
side of her face developed a slight sag, we went into panic mode. We conferred with her doctor, 
and stopped at the lab for her to have a battery of blood tests on our way to the clinic. The 
doctor confirmed the obvious: something was very wrong. There was an emergency MRI, a 
follow-up MRI, an immediate hospitalization, a spinal tap, visits from neurologists, and finally, a 
diagnosis: multiple sclerosis. These two words changed the world for our entire family. 
Multiple sclerosis is a neurological condition marked by inflammation resulting from 
autoimmune attacks to the myelin sheath on nerve cells in the brain and spinal cord. Once the 
myelin has sufficiently deteriorated, electrical impulses are no longer able to travel properly 
along the neurological pathways between cells. Demyelination appears as lesions on the brain 
and spine, and as white rings throughout the brain, both of which are visible on an MRI. It 
usually strikes young adults, and women more frequently than men. Symptoms include muscle 
spasticity, fatigue, bladder and bowel problems, motor dysfunction, cognitive difficulties, and 
vision issues (Neurological Disorders, p. 117). Patients’ experiences can range from a complete 
lack of symptoms to severe symptoms, culminating in death (Zarelli). 
The exact cause of MS is still uncertain. According to Kaiser Permanente MS specialist Dr. 
Greg Zarelli, neurologists generally agree that MS results from a combination of genetics, 
environment, and viral exposure—most likely to the Epstein-Barr virus. For many years, 
research has supported the likelihood that the disease is triggered by early viral infection and 
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subsequent autoimmune dysfunction (Bradshaw and Mattingley, p. 369). A child of an MS 
patient has a 1 in 25 chance of developing the condition, while the rest of the population has a 
1 in 600 chance (Zarelli). 
Researchers at Johns Hopkins University were kind enough to share data from ongoing 
research into the effects of MS on patients’ vision, specifically the anatomical changes within 
the retina. While it is a very small region, with the help of optical coherence tomography (OCT), 
researchers can examine separate parts of the retina that would be invisible to the human eye. 
Without the OCT, the only way to see the differences being measured would be with the 
removal of the eye. 
 Patients with MS have long been known to suffer deterioration of the retina, sometimes 
leading to blindness. Until now, researchers believed that deterioration occurs in the cells 
connecting the retinal cells to the optic nerve (Saidha, Primary Retinal Pathology, p. 519). 
Demyelination has been thought to be the root cause of these vision issues, as of other MS 
symptoms. However, findings from ongoing research at Johns Hopkins University, using OCT, 
showed a subgroup of multiple sclerosis patients for whom the deterioration occurs at a deeper 
level within the retina, between the photoreceptors and the connecting cells (Primary Retinal 
Pathology, p. 524, 528). This atypical progression is perplexing, as MS is considered primarily a 
demyelinating disease, and the area of the eye structure affected in this subset has no myelin 
to be damaged and is distal to the optic nerve. In the larger sense, the findings based on this 
data challenge what has been our understanding of what MS is and does. That discovery 
formed the impetus for this paper. 
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 It is impossible for readers to visualize the pertinent areas of deterioration in the retina 
without a basic understanding of the anatomy of the human eye. The retina forms a layer of 
tissue around the inside of the eyeball, anywhere that light could possibly reach inside the eye. 
Its function is to detect and interpret light, and then transmit the interpreted signals to the 
brain via the optic nerve (Dowling, p. 5). (See Figure 1) 
Using electronics metaphors, the retina is like a DVD reader, picking up and transporting 
visual signals. The optic nerve is the cable between the DVD player and the television. Inner 
structures of the brain act as the TV, processing and combining signals to create the TV picture 
with ‘sound’ and ‘color.’ The visual cortex displays the entire TV picture, with all the final 
adjustments. 
 
Figure 1: This image illustrates the structures of the eye. Provided by B. Antony. 
In the eye, light enters through the pupil. It reaches the retina, where it is absorbed by 
the photoreceptors (rods and cones). From there, visual information signals are transmitted 
through “intermediary” neuron cells to ganglion cells. Long, unmyelinated axons connect the 
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ganglion cells to the optic nerve. All of the neuron cells in this circuit are segregated into three 
distinct layers; the fibers connecting the retinal neurons form two separating layers, while the 
axon fibers running to the optic nerve form a third layer (Dowling, p. 19). 
 
 
Figure 2: The retina consists of many layers. The retinal nerve fiber layer (RNFL) is the layer closest to the 
inside of the eye; the retinal pigment epithelium (RPE) is the outermost boundary of the retina. In this study, 
the photoreceptor layer was divided into two sections: inner segments (IS) and outer segments (OS), and 
are here labeled as such. 
 
The outer nuclear layer (ONL) contains the nuclei and cell bodies of the photoreceptor 
cells. The cell bodies of ‘intermediary’ retinal neurons are found in the inner nuclear layer (INL). 
The synaptic connections between the two nuclear layers form the outer plexiform layer (OPL), 
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while the connections between the INL and the ganglion cells form the inner plexiform layer 
(IPL). The ganglion cell bodies are in their own layer, the ganglion cell layer (GC); the layer of 
axonal “nerve fibers” connecting the ganglion cells to the optic nerve is called the retinal nerve 
fiber layer (RNFL). Occasionally, cells may be found outside the typical location—for instance, 
ganglion cells have been observed within the inner nuclear layer (Dowling, p. 19). 
A neuron has dendrites at one end, and an axon, coated by the myelin sheath, on the 
other.  The axon has spaces (nodes of Ranvier) between segments of myelin that the nerve 
signals jump. In the peripheral nervous system (PNS), Schwann cells wrap around the axon to 
build the myelin sheath and clear away debris from their area of the axon; Schwann cells 
control only the one segment they comprise (Vargas, p. 160). In the central nervous system 
(CNS), instead of Schwann cells, the axon and its myelin sheath are controlled by 
oligodendrocytes. Picture an octopus, with each tentacle dedicated to one of the segments.  
Herein lies the anomaly that is our current focus: the PNS, with its Schwann cells, 
regenerates myelin when damaged. Because each gap has its own support cells, lost areas of 
myelin can recover from damage. In the CNS, however, if the myelin is damaged, the debris is 
not cleared, and the oligodendrocyte does not regenerate (Vargas, p. 155). In the retina, 
neither the myelin nor the oligodendrocytes are present. And yet, there is still measurable 
degeneration. The degeneration is so unexpected and unaccountable that researchers were 
forced to draw the conclusion that they were observing some sub-type of MS retinal pathology 
that had not yet been identified. 
These findings are significant because they raise the possibilities that there are other 
causes of MS than demyelination. The location of this degeneration is also important because 
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the retina is the easiest of the MS-degenerating regions to be observed in a living person. We 
may find that the retina, which is connected through the optic nerve and is part of the central 
nervous system, will make it easier to observe changes affecting the entire CNS. It is also 
important that, as 99% of deceased MS patients show these retinal changes to a significant 
extent, we can be certain they are related to the disease. That the retinal degeneration from 
this ‘demyelinating’ disease is also happening where there is no myelin frustrates explanation 
when we look at what MS reportedly does to cause degeneration. While it is widely accepted 
that there is much we do not know about this disease, there are indicators in this data that we 
know even less than formerly thought. 
The findings at Johns Hopkins have met with some opposition from researchers. After 
Saidha, et al, published this research in the article, “Primary Retinal Pathology in Multiple 
Sclerosis as Detected by Optical Coherence Tomography,” a German research team vehemently 
disagreed in a letter to the editors of Brain, the journal that had published the finding. The 
team of writers, Brandt et al, looked at the data from their own cohort and argued that, rather 
than a special subset, the findings could be explained by extreme cases of normal progression. 
The German team claimed that the grouping criteria defined by the researchers at Johns 
Hopkins created a significant difference where none actually existed. 
Several inconsistencies are apparent when examining the Brandt argument. As the 
researchers at Johns Hopkins stated in their rebuttal, different scanners were used by the two 
research groups, which can cause noticeable variations in data. Secondly, in analyzing their data, 
the German research team used a scatter plot and linear regression analysis, while the Johns 
Hopkins team used standard T-testing. Finally, geographic location and nationality could be a 
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confounding variable as the frequency of MS has varied geographically (Reply: Primary Retinal 
Pathology). The Johns Hopkins team did not mention in its rebuttal another factor, specifically 
that the Germans compared total macular volume against the average RNFL thickness, whereas 
the original study used average overall macular thickness. The differences in method would 
almost certainly give differing results.  
Methodology 
Johns Hopkins University provided data for macular layer thickness, obtained using 
Spectralis OCT imaging and segmentation protocols. Technicians took retinal scans of 142 
patients with relapsing-remitting multiple sclerosis (RRMS) and 114 control subjects. These 
formed the basis of the multiple sclerosis (MS) and healthy control (HC) subject groups. Some 
of the subjects from the HC were excluded if they had pre-existing conditions that would 
interfere with establishing a “normal” against which to compare patient data. Additionally, 
subjects from both the MS and the HC group were excluded if OCT data for only one eye was 
available; where more than one scan was provided for one eye, the first was kept (unless 
otherwise specified), and the extras were excluded from analysis. 
After exclusions, there were 133 subjects in the MS group and 96 subjects in the HC 
group. The average of left and right eye data was subsequently determined for each subject 
and used for analysis. Following criteria laid out in “Primary Retinal Pathology” (p. 519-20), the 
MS group was divided into three smaller groups for analysis. The original criteria compared MS 
patient data against a database of controls, setting “normal” values as between the 5th and 95th 
percentiles of the control database and “below normal” values as less than the 5th percentile 
(Primary Retinal Pathology, p. 522). Group 1, labeled “macular thinning predominant” (MTP), 
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contained subjects demonstrating “below normal” macular thickness and “normal” RNFL 
thickness. Group 3, labeled MSN for “multiple sclerosis – normal scans”, contained subjects 
demonstrating “normal” RNFL and average macular thicknesses. Group 4, labeled HC for 
“healthy controls”, contained the set of healthy subjects exhibiting no symptoms of optic 
deterioration. Group 2 contained MS patients demonstrating the “abnormalities typical of 
those seen in multiple sclerosis—‘below normal’ RNFL thicknesses on OCT, regardless of 
macular thinning.” The group was labeled MSA for “multiple sclerosis – abnormal scans”. In this 
thesis, these grouping criteria were partially replicated; in place of the database, the percentiles 
were defined exclusively using the HC data provided. According to the Johns Hopkins team, no 
comparable database currently exists. 
 
Figure 3: The Venn diagram above illustrates the grouping criteria at work.  
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The Venn diagram in Figure 3 helps visualize the groupings. Group 1 is patients with 
overall macular thinning without thinning of the RNFL. Group 2 is all patients exhibiting thinning 
of the RFNL, whether or not they have overall thinning. Group 3 patients don’t show thinning in 
any layer. Group 4, seeming to be unconnected to the others, is the control group, people who 
do not have MS or any other preexisting condition that could affect the retina.  
Wilcoxon testing was used to compare average thicknesses of each layer between 
groups, and a p-value of less than 0.001 was considered significant. Since we used an alpha of 
0.001 for each comparison, by Bonferroni’s inequality [1- (1-α)(# of comparisons)], the overall 
significance level of these tests is bounded above by 0.054. If we had used an alpha of 0.0001, 
we could have made an overall significance level bounded above by less than 1%. However, the 
individual alpha would have been very small, which means we might not have detected a 
difference where one actually exists. 
Results 
 MTP and MSA demonstrated significant thinning in the RNFL compared to MSN and to 
HC (p< .001 for all). RNFL was significantly thinner in MSA compared to MTP, as well (p < .001). 
MSN was not significantly different from HC in RNFL or overall macular thickness. The GC-IPL of 
MTP and MSA subjects were not significantly different; however, both were significantly 
thinner than MSN, and all MS subjects had significantly thinner GC-IPLs compared to HC 
(p< .001).  
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Figure 4 The table above contains the test results for each individual Wilcoxon test. All results with a p-value less than 0.001 are 
reported as such. Grp 1 = MTP, Grp 2 = MSA, Grp 3 = MSN, Grp 4 = HC.  
 The INL in MTP was significantly thinner than MSA, MSN, and HC (p< .001). Neither MSA 
nor MSN demonstrated significant differences in the INL against HC or each other. The OPL was 
thinner in MTP compared to MSA (p = .002), MSN (p< .001), and HC (p = .006), as well, without 
significant differences among the three. The ONL and IS layer were similarly significantly thinner 
in MTP compared to the other three groups (p< .001 for MTP vs all). There is evidence to 
support a claim of significant difference in the OS layer as well: MTP against MSA (p = .010), 
MSN (p = .003), and HC (p = .002), with little to no difference among non-MTP groups. No 
significant results were found within the RPE. 
Analysis 
The MTP group displayed significant thinning of the inner nuclear and outer nuclear 
layers, which was not found in either of the non-MTP MS groups. This supports the findings of 
the earlier Johns Hopkins University study, and suggests a previously unrecognized pathology in 
retinal neurodegeneration. However, at this time, it cannot be definitively claimed that this loss 
is not as a result of retrograde degeneration of the RNFL and subsequent neurodegeneration of 
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the retina—the accepted explanation before now. So, while it needs further support, it appears 
that degeneration does not stop at the first two layers, as has previously been posited (Primary 
Retinal Pathology, p. 208). While the damage to those two layers makes sense, given the 
presence of myelin in the optic nerve, the severity of degeneration present in the deeper 
retinal layers does not. As there is no myelin, there must be another explanation for the 
damage. 
Furthermore, the MTP group displayed significant thinning in the inner portion of the 
photoreceptor segments (IS). Evidence suggests less significant thinning observed within the 
OPL as well, although the observation may be attributed to chance. Together with the ONL 
thinning, however, there is ample evidence to suggest that the photoreceptor cells, which 
compose much of the outer layers, are somehow involved with the observed thinning present 
in the MTP group. Further research may be enhanced by a concentration on this region in the 
retina. 
While the research is highly suggestive, there are design issues to be addressed: 
database and experimental design. The database does not exist; while a database was used for 
the grouping criteria in the original study, the comparison control group was used as an 
alternative in this study. This weakens our ability to generalize our findings. Further design 
issues include a too-small pool of patients—only about half—with corresponding EDSS scores, 
and averaging measurements may have reduced sensitivity. 
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Conclusion 
 There is clear support for a new subset of MS patients with retinal damage beyond the 
first two layers. The etiology remains unclear. This conclusion agrees with the findings of 
Saidha’s earlier study, as was anticipated.  
 One of Saidha’s concerns was that grouping criteria are based only on RNFL and overall 
macular thickness among MS patients, and those experiencing retrograde degeneration as well 
as the degeneration described in the MTP group fail to be recognized. This appears to be a valid 
concern, and further criteria based around the deeper layers must be developed.  
 An interesting question remains: What exactly is happening deep in the retina where 
degeneration is occurring? Why is there degeneration where there is no myelin, under the 
normally affected retinal layers, when those layers may not show any degeneration? What is 
the process that is occurring that seems to have nothing to do with the demyelination that 
defines MS?  
 In the retina, where there is no myelin, we still find glial cells. Though oligodendrocytes 
are glial cells found throughout the central nervous system, they are completely absent from 
the retina. So why in the retina is there a parallel cell, an octopus like the oligodendrocytes, 
where there is no octopus work to be done? It suggests that the structures of the parallel cell 
have some function beyond maintaining and controlling the myelin sheath. We can make many 
speculations. For example, that function might have something to do with the blood-brain 
barrier, or amplification of nerve impulses, or the macrophagic (immune) system, or even 
something else that has not yet been examined. We do not yet know. The findings merit more 
research, likely with exciting results.  
Festner 16 
Bibliography 
 
Bradshaw, John L. and Jason B. Mattingley. Clinical Neuropsychology. San Diego: Academic 
Press, Inc., 1995. Print. 
Brandt, A. U. et al. “Primary Retinal Pathology in Multiple Sclerosis as Detected by Optical 
Coherence Tomography.” Brain 134.11 (2011): e193–e193. Web. 
Dowling, John. The Retina: An Approachable Part of the Brain. Cambridge: Belknap Press, 2012. 
Print. 
June Halper and Nancy Joyce Holland, eds. Comprehensive Nursing Care in Multiple Sclerosis. 
New York: Springer Publishing Company, 2011. Print. 
“Multiple Sclerosis.” Neurologic Disorders. 2010. Print.  
Saidha, Shiv et al. “Primary Retinal Pathology in Multiple Sclerosis as Detected by Optical 
Coherence Tomography.” Brain 134.2 (2011): 518–533. Web. 
---. “Reply: Primary Retinal Pathology in Multiple Sclerosis as Detected by Optical Coherence 
Tomography.” Brain 134.11 (2011): e194–e194. Web. 
Trapp, Bruce D., and Klaus-Armin Nave. “Multiple Sclerosis: An Immune or Neurodegenerative 
Disorder?” Annual Review of Neuroscience 31.1 (2008): 247–269. Web. 
Vargas, Mauricio E., and Ben A. Barres. “Why Is Wallerian Degeneration in the CNS So Slow?” 
Annual Review of Neuroscience 30.1 (2007): 153–179. Web. 
Weiner, Howard L., M.D. Curing MS: How Science is Solving the Mysteries of Multiple Sclerosis. 
New York: Three Rivers Press, 2005. Print.  
Festner 17 
Zarelli, Greg, M.D. Personal interview at Kaiser Permanente Sunnyside, OR Campus. 12 May 
2015. 
Festner 18 
Appendix 
 
Figure 5 A chart illustrating the average thicknesses of each layer, and overall, for each group. 
